These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6489930)

  • 21. [A case of insulin receptor abnormality (type A)].
    Kamada T; Horinosono M; Nishi M; Setoyama M; Oki T; Nagata Y; Arima T; Tashiro M; Otsuji S
    Igaku Kenkyu; 1992 Feb; 62(1):25-9. PubMed ID: 1523941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amenorrhea, insulin resistance and acanthosis nigricans. A hyperandrogenic and a normoandrogenic clinical forms].
    Devoto E; Aravena L; Pacheco D; Fluxá F
    Rev Med Chil; 1993 Feb; 121(2):170-5. PubMed ID: 8303114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.
    Kahn CR; Baird K; Filier JS; Jarrett DB
    J Clin Invest; 1977 Nov; 60(5):1094-106. PubMed ID: 908753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of acanthosis nigricans in childhood obesity.
    Guran T; Turan S; Akcay T; Bereket A
    J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk.
    Stuart CA; Smith MM; Gilkison CR; Shaheb S; Stahn RM
    Am J Public Health; 1994 Nov; 84(11):1839-42. PubMed ID: 7977931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acanthosis nigricans, hyperandrogenism, insulin resistance and mixed hyperlipemia].
    Thivolet CH; Mauduit G; Canivet B; Garrel D; Tourniaire J; Thivolet J; Pugeat M
    Presse Med; 1988 Jul; 17(26):1355-9. PubMed ID: 2970081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.
    Nestler JE; Clore JN; Strauss JF; Blackard WG
    J Clin Endocrinol Metab; 1987 Jan; 64(1):180-4. PubMed ID: 2946716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acanthosis nigricans, insulin resistance and cutaneous virilism.
    Barth JH; Ng LL; Wojnarowska F; Dawber RP
    Br J Dermatol; 1988 May; 118(5):613-9. PubMed ID: 3293647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of a primary (? genetic) defect in insulin receptors in fibroblasts from a patient with the syndrome of insulin resistance and acanthosis nigricans type A.
    Kahn CR; Podskalny JM
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1139-41. PubMed ID: 6989852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial insulin resistance and acanthosis nigricans.
    Praptono R; Sunartini ; Djunduah ; Sadjimin T
    Paediatr Indones; 1990; 30(7-8):213-21. PubMed ID: 2075024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the type A syndrome of insulin resistance.
    Grigorescu F; Flier JS; Kahn CR
    Diabetes; 1986 Feb; 35(2):127-38. PubMed ID: 3510919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of specific histocompatibility antigens and acanthosis nigricans with insulin resistance.
    Saad MJ; Monteiro CM; Eizirik DL; Foss MC
    Braz J Med Biol Res; 1990; 23(10):959-64. PubMed ID: 2101060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial type C syndrome of insulin resistance and short stature with possible autosomal dominant transmission.
    Nakamura F; Taira M; Hashimoto N; Makino H; Sasaki N
    Endocrinol Jpn; 1989 Jun; 36(3):349-58. PubMed ID: 2684618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of pancreatic beta-cell secretion during a "glucose-clamp" in subjects with acanthosis nigricans].
    Sinagra D; Randazzo C; Mistretta A; Pugliese A
    Minerva Med; 1989 Mar; 80(3):233-5. PubMed ID: 2654759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel insulin receptor mutation in an adolescent with acanthosis nigricans and hyperandrogenism.
    Krishnamurthy M; Pingul MM
    J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1201-1205. PubMed ID: 27505086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of insulin resistance associated with acanthosis nigricans.
    Fukushima N; Matsuura N; Nohara Y; Fujita H; Endo M; Abe K; Kosaka S; Satomi S
    Tohoku J Exp Med; 1984 Oct; 144(2):129-38. PubMed ID: 6393448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptors, antireceptor antibodies and mechanisms of insulin resistance.
    Flier JS; Kahn CR; Roth J
    N Engl J Med; 1979 Feb; 300(8):413-9. PubMed ID: 366414
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical significance of pancreatic beta-cell function in obese children with acanthosis nigricans].
    Liang XJ; Zhu C; Yan C; Ni GC; Liu ZL; Du ZM; Li M
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):405-7. PubMed ID: 15265420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.
    Kahn CR; Flier JS; Bar RS; Archer JA; Gorden P; Martin MM; Roth J
    N Engl J Med; 1976 Apr; 294(14):739-45. PubMed ID: 176581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with acanthosis nigricans in obese adolescents.
    Galhardo J; Hunt LP; Shield JP
    Diabet Med; 2012 Jul; 29(7):e117-20. PubMed ID: 22288782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.